The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
mtDNA mutations increase tumorigenicity in prostate cancer
Open accessAbstract
Mutations in the mtDNA have been found to fulfill all of the criteria expected for pathogenic mutations causing prostate cancer. Focusing on the cytochrome oxidase subunit I (COI) gene, we found that 11–12% of all prostate cancer patients harbored COI mutations that altered conserved amino acids (mean conservation index = 83%), whereas <2% of no-cancer controls and 7.8% of the general population had COI mutations, the latter altering less conserved amino acids (conservation index = 71%). Four conserved prostate cancer COI mutations were found in multiple independent patients on different mtDNA backgrounds. Three other tumors contained heteroplasmic COI mutations, one of which created a stop codon. This latter tumor also contained a germ-line ATP6 mutation. Thus, both germ-line and somatic mtDNA mutations contribute to prostate cancer. Many tumors have been found to produce increased reactive oxygen species (ROS), and mtDNA mutations that inhibit oxidative phosphorylation can increase ROS production and thus contribute to tumorigenicity. To determine whether mutant tumors had increased ROS and tumor growth rates, we introduced the pathogenic mtDNA ATP6 T8993G mutation into the PC3 prostate cancer cell line through cybrid transfer and tested for tumor growth in nude mice. The resulting mutant (T8993G) cybrids were found to generate tumors that were 7 times larger than the wild-type (T8993T) cybrids, whereas the wild-type cybrids barely grew in the mice. The mutant tumors also generated significantly more ROS. Therefore, mtDNA mutations do play an important role in the etiology of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variable Number of Tandem Repeat (VNTR) Markers for Human Gene Mapping
Nakamura, Y., Leppert, M., O'Connell, P., Wolff, R., Holm, T., Culver, M., Martin, C., Fujimoto, E., Hoff, M., Kumlin, E., et al. (1987) · Science · doi:10.1126/science.3029872 · Cited by 1,654
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The evolution of free radicals and oxidative stress
McCord, J. M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00412-5 · Cited by 1,407
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., & Wallace, D. C. (2004) · Nature · doi:10.1038/nature02229 · Cited by 1,086
Self-citationNatural selection shaped regional mtDNA variation in humans
Mishmar, D., Ruiz-Pesini, E., Golik, P., Macaulay, V., Clark, A. G., Hosseini, S., Brandon, M., Easley, K., Chen, E., Brown, M. D., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136972100 · Cited by 1,038
Self-citationA new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Holt, I. J., Harding, A. E., Petty, R., & MORGAN-HUGHES, J. A. (1990) · PubMed · Cited by 1,005
Lee, S.-R., Kwon, K.-S., Kim, S.-R., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15366 · Cited by 969
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Somatic mutations of the mitochondrial genome in human colorectal tumours
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K. V., Markowitz, S. D., Trush, M. A., Kinzler, K. W., & Vogelstein, B. (1998) · Nature Genetics · doi:10.1038/3108 · Cited by 835
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808
Effects of Purifying and Adaptive Selection on Regional Variation in Human mtDNA
Ruiz-Pesini, E., Mishmar, D., Brandon, M., Procaccio, V., & Wallace, D. C. (2004) · Science · doi:10.1126/science.1088434 · Cited by 806
Self-citationTrounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746
Self-citationBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730
A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.
Ishii, N., Fujii, M., Hartman, P. S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Ayusawa, D., & Suzuki, K. (1998) · Nature · doi:10.1038/29331 · Cited by 687
Mitochondrial disease in mouse results in increased oxidative stress
Esposito, L. A., Melov, S., Panov, A., Cottrell, B. A., & Wallace, D. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4820 · Cited by 639
Self-citationGraham, B. H., Waymire, K. G., Cottrell, B., Trounce, I. A., MacGregor, G. R., & Wallace, D. C. (1997) · Nature Genetics · doi:10.1038/ng0797-226 · Cited by 556
Self-citationEvans, A. R., Limp-Foster, M., & Kelley, M. R. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00046-x · Cited by 532
Mitochondrial DNA mutations in human colonic crypt stem cells
Taylor, R. W., Barron, M. J., Borthwick, G. M., Gospel, A., Chinnery, P. F., Samuels, D. C., Taylor, G. A., Plusa, S. M., Needham, S. J., Greaves, L. C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19435 · Cited by 530
Emery and Rimoin's Principles and Practice of Medical Genetics
Rimoin, D. L. (1997) · Cited by 524
Vanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389
Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue
Goldsworthy, S. M., Stockton, P. S., Trempus, C. S., Foley, J. F., & Maronpot, R. R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199906)25:2<86::aid-mc2>3.0.co;2-4 · Cited by 345
Senoo-Matsuda, N., Yasuda, K., Tsuda, M., Ohkubo, T., Yoshimura, S., Nakazawa, H., Hartman, P. S., & Ishii, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104718200 · Cited by 271
Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<123::aid-cncr17>3.0.co;2-9 · Cited by 269
Chinnery, P. F., Samuels, D. C., Elson, J., & Turnbull, D. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11310-9 · Cited by 235
Mitochondrial mutations in early stage prostate cancer and bodily fluids
Jerónimo, C., Nomoto, S., Caballero, O. L., Usadel, H., Henrique, R., Varzim, G., Oliveira, J., Lopes, C., Fliss, M. S., & Sidransky, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204646 · Cited by 226
Mitochondrial DNA Alterations in Cancer
Copeland, W. C., Wachsman, J. T., Johnson, F. M., & Penta, J. S. (2002) · Cancer Investigation · doi:10.1081/cnv-120002155 · Cited by 224
Mattiazzi, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh103 · Cited by 221
Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes
Michiels, C., Minet, E., Mottet, D., & Raes, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01045-6 · Cited by 201
Trounce, I., Neill, S., & Wallace, D. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8334 · Cited by 192
Self-citationTarget to apoptosis: A hopeful weapon for prostate cancer
Tang, D. G., & Porter, A. T. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970901)32:4<229::aid-pros1>3.0.co;2-e · Cited by 191
Novel mitochondrial DNA deletion found in a renal cell carcinoma
Horton, T. M., Petros, J. A., Heddi, A., Shoffner, J., Kaufman, A. E., Graham, S. D., Gramlich, T., & Wallace, D. C. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<95::aid-gcc3>3.0.co;2-z · Cited by 162
Self-citationGattermann, N., Retzlaff, S., Wang, Y.-L., Hofhaus, G., Heinisch, J., Aul, C., & Schneider, W. (1997) · Blood · doi:10.1182/blood.v90.12.4961 · Cited by 160
Mishmar, D., Ruiz‐Pesini, E., Brandon, M., & Wallace, D. C. (2004) · Human Mutation · doi:10.1002/humu.10304 · Cited by 151
Self-citationMitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer
Herrmann, P. C., Gillespie, J. W., Charboneau, L., Bichsel, V. E., Paweletz, C. P., Calvert, V. S., Kohn, E. C., Emmert‐Buck, M. R., Liotta, L. A., & Petricoin, E. F. (2003) · PROTEOMICS · doi:10.1002/pmic.200300461 · Cited by 151
Xu, Y., Krishnan, A., Wan, X. S., Majima, H. J., Yeh, C., Ludewig, G., Kasarskis, E. J., & Clair, D. K. S. (1999) · Oncogene · doi:10.1038/sj.onc.1202265 · Cited by 136
Chen, J. Z., Gökden, N., Greene, G. F., Mukunyadzi, P., & Kadlubar, F. F. (2002) · PubMed · Cited by 125
Pallotti, F., Baracca, A., Hernandez-Rosa, E., Walker, W. F., Solaini, G., Lenaz, G., d'ERIL, G. V. M., DiMauro, S., Schon, E. A., & Davidson, M. M. (2004) · Biochemical Journal · doi:10.1042/bj20040561 · Cited by 98
Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines.
Howell, A., & Sager, R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2358 · Cited by 97
Krieg, R. C., Knuechel, R., Schiffmann, E., Liotta, L. A., Petricoin, E. F., & Herrmann, P. C. (2004) · PROTEOMICS · doi:10.1002/pmic.200300796 · Cited by 64
Wallace, D. C. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.8.697 · Cited by 49
Self-citationArbiser, J. L. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.013 · Cited by 43
Cited by
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Self-citationWallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Self-citationExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Self-citationTargeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Metadata
- Authors
- Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., Marshall, F. F., & Wallace, D. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-01-12
- Volume
- 102
- Issue
- 3
- Pages
- 719-724
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2163069284
- Cited by
- 836
- References
- 43
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.